STADA Arzneimittel AG 08.04.2014 10:45 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Correction of a notification dated 28.03.2014 Pursuant to sections 21 (1), 24 WpHG ('German Securities Trading Act'), Deutsche Bank AG, London Branch, Great Britain, notified us on 4th of April 2014 that the percentage of voting rights of its subsidiary Deutsche Asset & Wealth Management Investment GmbH, Frankfurt, Germany, in STADA Arzneimittel AG, Bad Vilbel, Germany, crossed the threshold of 5 % on 27th of March 2014 and amounts to 5,49 % (3.316.851 voting rights) as per this date. Pursuant to section 22 para. 1 sentence 1 no. 6 WpHG 0,11 % (65.683 voting rights) are to be attributed to Deutsche Asset & Wealth Management Investment GmbH, Frankfurt, Germany. 08.04.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: STADA Arzneimittel AG StadastraÃe 2-18 61118 Bad Vilbel Germany Internet: www.stada.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-PVR: STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Correction -
| Source: EQS Group AG